Position in NUVB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$8,593,331
-$8,625,385 QoQ
Shares Held
2,003,108
+4.2% QoQ
Ownership
0.575%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. NUVB ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,593,331 | 2,003,108 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $17,218,716 | 1,921,732 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,835,384 | 2,117,672 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,064,123 | 2,084,167 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,549,326 | 2,016,665 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,550,756 | 2,086,751 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,487,952 | 1,523,124 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $3,700,558 | 1,267,315 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $4,482,065 | 1,231,337 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,842,556 | 1,220,237 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,743,117 | 1,300,835 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,252,760 | 1,251,534 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,780,426 | 1,072,547 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,049,642 | 1,067,523 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,302,781 | 1,028,028 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,357,591 | 1,036,294 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,175,160 | 1,364,099 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,031,291 | 1,415,446 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $7,413,042 | 745,779 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,467,513 | 479,862 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,238,972 | 118,562 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||